UiPath (NYSE:PATH) Stock Price Down 0.4%

UiPath Inc. (NYSE:PATH) fell 0.4% during mid-day trading on Wednesday . The stock traded as low as $19.15 and last traded at $19.41. 7,327,104 shares changed hands during mid-day trading, an increase of 21% from the average session volume of 6,060,729 shares. The stock had previously closed at $19.48.

Analysts Set New Price Targets

Several brokerages recently weighed in on PATH. Scotiabank boosted their price objective on shares of UiPath from $29.00 to $30.00 and gave the stock a “sector perform” rating in a research note on Thursday, March 14th. Morgan Stanley increased their price target on UiPath from $17.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. BMO Capital Markets lifted their price objective on UiPath from $24.00 to $28.00 and gave the stock a “market perform” rating in a research note on Thursday, March 14th. Barclays increased their target price on shares of UiPath from $23.00 to $25.00 and gave the company an “equal weight” rating in a research report on Friday, March 15th. Finally, Wells Fargo & Company upped their price objective on shares of UiPath from $24.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, March 14th. Nine equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, UiPath has an average rating of “Moderate Buy” and a consensus target price of $27.41.

UiPath Stock Performance

The stock’s 50 day simple moving average is $22.97 and its 200 day simple moving average is $21.44. The firm has a market cap of $10.83 billion, a P/E ratio of -111.96 and a beta of 0.96.

UiPath (NYSE:PATH) last posted its earnings results on Wednesday, March 13th. The healthcare company reported $0.06 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.10. UiPath had a negative net margin of 6.87% and a negative return on equity of 3.29%. The company had revenue of $405.25 million during the quarter, compared to the consensus estimate of $383.32 million. As a group, analysts forecast that UiPath Inc. will post -0.04 EPS for the current fiscal year.

Insider Activity

In other UiPath news, CFO Ashim Gupta sold 16,000 shares of the firm’s stock in a transaction on Friday, March 15th. The stock was sold at an average price of $22.84, for a total transaction of $365,440.00. Following the transaction, the chief financial officer now directly owns 87,505 shares in the company, valued at approximately $1,998,614.20. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders have sold 72,000 shares of company stock worth $1,591,360 over the last 90 days. 31.03% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Raymond James Financial Services Advisors Inc. increased its position in shares of UiPath by 3.8% in the first quarter. Raymond James Financial Services Advisors Inc. now owns 40,993 shares of the healthcare company’s stock worth $885,000 after purchasing an additional 1,506 shares during the last quarter. MetLife Investment Management LLC purchased a new stake in UiPath during the first quarter valued at about $184,000. BlackRock Inc. boosted its holdings in shares of UiPath by 1.9% in the 1st quarter. BlackRock Inc. now owns 5,316,635 shares of the healthcare company’s stock worth $114,786,000 after purchasing an additional 99,242 shares in the last quarter. Dimensional Fund Advisors LP purchased a new position in shares of UiPath during the 1st quarter valued at about $534,000. Finally, Canada Pension Plan Investment Board bought a new stake in UiPath in the 1st quarter worth approximately $259,000. Hedge funds and other institutional investors own 62.50% of the company’s stock.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.